Schedule 13G ownership disclosure

EUPRAXIA PHARMACEUTICALS INC

Common Shares · CUSIP: 29842P105

Event date: 2025-09-30

Filing-level shares
4,058,899.00
Percent of class
8.0%
  • Beutel, Goodman & Co Ltd.

    Shares: 4,058,899.00 · Class: 8.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001361974-25-000015
Form type
SCHEDULE 13G
Filer
Beutel, Goodman & Co Ltd.
CIK
CIK 1361974
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub